iCAD, Inc. Takes Leadership Position in Meeting the Need for Accredited Educational Initiatives on Prostate and Breast MRI Imaging Technologies

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announces upcoming educational initiatives for physicians who diagnose and treat patients with breast and prostate cancers. iCAD has provided a grant to ICPME for a comprehensive educational webinar series. These accredited educational webinar sessions will be offered throughout 2010 with presentations by expert clinical faculty from leading institutions across the country and are designed to:
MORE ON THIS TOPIC